| Year |
Citation |
Score |
| 2024 |
Churchill CC, Peterson CD, Kitto KF, Pflepsen KR, Belur LR, McIvor RS, Vulchanova L, Wilcox GL, Fairbanks CA. Adeno-associated virus-mediated gene transfer of arginine decarboxylase to the central nervous system prevents opioid analgesic tolerance. Frontiers in Pain Research (Lausanne, Switzerland). 4: 1269017. PMID 38405182 DOI: 10.3389/fpain.2023.1269017 |
0.484 |
|
| 2023 |
Clements BM, Peterson CD, Kitto KF, Caye LD, Wilcox GL, Fairbanks CA. Biodistribution of Agmatine to Brain and Spinal Cord after Systemic Delivery. The Journal of Pharmacology and Experimental Therapeutics. 387: 328-336. PMID 37770201 DOI: 10.1124/jpet.123.001828 |
0.584 |
|
| 2023 |
Peterson CD, Waataja JJ, Kitto KF, Erb S, Verma H, Schuster DJ, Churchill CC, Riedl MS, Belur LR, Wolf DA, McIvor RS, Vulchanova L, Wilcox GL, Fairbanks CA. Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36710491 DOI: 10.1016/j.ymthe.2023.01.022 |
0.744 |
|
| 2021 |
Griffith JI, Kim M, Bruce DJ, Peterson CD, Kitto KF, Mohammad AS, Rathi S, Fairbanks CA, Wilcox GL, Elmquist WF. CNS Distribution of an Opioid Agonist Combination with Synergistic Activity. The Journal of Pharmacology and Experimental Therapeutics. PMID 34663676 DOI: 10.1124/jpet.121.000821 |
0.621 |
|
| 2021 |
Pflepsen KR, Peterson CD, Kitto KF, Riedl MS, McIvor RS, Wilcox GL, Vulchanova L, Fairbanks CA. Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection. Molecular Pharmaceutics. PMID 34460254 DOI: 10.1021/acs.molpharmaceut.1c00252 |
0.565 |
|
| 2021 |
Peterson CD, Kitto KF, Verma H, Pflepsen K, Delpire E, Wilcox GL, Fairbanks CA. Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain. Molecular Pain. 17: 17448069211029171. PMID 34210178 DOI: 10.1177/17448069211029171 |
0.615 |
|
| 2020 |
Larson CM, Peterson CD, Kitto KF, Wilcox GL, Fairbanks CA. Sustained-release buprenorphine induces acute opioid tolerance in the mouse. European Journal of Pharmacology. 173330. PMID 32726653 DOI: 10.1016/J.Ejphar.2020.173330 |
0.612 |
|
| 2019 |
Larson CM, Wilcox GL, Fairbanks CA. Defining and Managing Pain in Stroke and Traumatic Brain Injury Research. Comparative Medicine. 69: 510-519. PMID 31896392 DOI: 10.30802/Aalas-Cm-19-000099 |
0.6 |
|
| 2019 |
Larson CM, Wilcox GL, Fairbanks CA. The Study of Pain in Rats and Mice. Comparative Medicine. PMID 31822322 DOI: 10.30802/Aalas-Cm-19-000062 |
0.592 |
|
| 2019 |
Shah R, Peterson C, Strom A, Dillenburg M, Finzel BC, Kitto KF, Fairbanks CA, Wilcox GL, Wagner CR. Inhibition of Hint1 Modulates Spinal Nociception and NMDA Evoked Behavior in Mice. Acs Chemical Neuroscience. PMID 31503445 DOI: 10.1021/Acschemneuro.9B00432 |
0.667 |
|
| 2019 |
Bruce DJ, Peterson CD, Kitto KF, Akgün E, Lazzaroni S, Portoghese PS, Fairbanks CA, Wilcox GL. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice. Anesthesiology. PMID 31343460 DOI: 10.1097/Aln.0000000000002840 |
0.652 |
|
| 2019 |
Peterson CD, Skorput AGJ, Kitto KF, Wilcox GL, Vulchanova L, Fairbanks CA. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection. Methods in Molecular Biology (Clifton, N.J.). 1950: 199-207. PMID 30783975 DOI: 10.1007/978-1-4939-9139-6_11 |
0.628 |
|
| 2019 |
Pflepsen KR, Peterson CD, Kitto KF, Vulchanova L, Wilcox GL, Fairbanks CA. Detailed Method for Intrathecal Delivery of Gene Therapeutics by Direct Lumbar Puncture in Mice. Methods in Molecular Biology (Clifton, N.J.). 1937: 305-312. PMID 30706406 DOI: 10.1007/978-1-4939-9065-8_20 |
0.552 |
|
| 2019 |
Bruce D, Peterson C, Fairbanks C, Wilcox G. (260) Examining Sex Differences in Analgesic Tolerance to a Peripherally-Restricted Opioid combination The Journal of Pain. 20: S39. DOI: 10.1016/J.Jpain.2019.01.182 |
0.649 |
|
| 2019 |
Peterson C, Wataaja J, Kitto K, Verma H, Delpire E, Wilcox G, Fairbanks C. (219) Selective Antagonism of Spinal GluN2B EPSCs by Agmatine The Journal of Pain. 20: S30. DOI: 10.1016/J.Jpain.2019.01.140 |
0.666 |
|
| 2018 |
Waataja JJ, Peterson CD, Verma H, Goracke-Postle CJ, Séguéla P, Delpire E, Wilcox GL, Fairbanks CA. Agmatine Preferentially Antagonizes GluN2B-Containing N-Methyl-D-Aspartate Receptors in Spinal Cord. Journal of Neurophysiology. PMID 30427758 DOI: 10.1152/Jn.00172.2018 |
0.819 |
|
| 2018 |
Skorput AGJ, Zhang X, Waataja JJ, Peterson CD, Riedl MS, Kitto KF, Truong H, Huffman C, Salton SR, Fairbanks CA, Honda CN, Vulchanova L. Involvement of the VGF-derived peptide TLQP-62 in nerve injury-induced hypersensitivity and spinal neuroplasticity. Pain. PMID 29781959 DOI: 10.1097/J.Pain.0000000000001277 |
0.447 |
|
| 2018 |
Larson C, Peterson C, Bruce D, Kitto K, Fairbanks C, Wilcox G. Peripherally restricted opioid combination therapy reduces pain behavior in mouse and pig The Journal of Pain. 19: S79. DOI: 10.1016/J.Jpain.2017.12.188 |
0.628 |
|
| 2018 |
Peterson C, Wataaja J, Kitto K, Verma H, Delpire E, Wilcox G, Fairbanks C. Agmatine reduction of neuropathic pain requires spinal NMDA receptors containing GluN2B subunits The Journal of Pain. 19: S79. DOI: 10.1016/J.Jpain.2017.12.186 |
0.651 |
|
| 2017 |
Peterson CD, Kitto KF, Akgün E, Lunzer MM, Riedl MS, Vulchanova L, Wilcox GL, Portoghese PS, Fairbanks CA. A bivalent ligand that activates mu opioid receptor and antagonizes mGluR5 receptor reduces neuropathic pain in mice. Pain. PMID 28891868 DOI: 10.1097/J.Pain.0000000000001050 |
0.665 |
|
| 2017 |
Doolen S, Cook J, Riedl M, Kitto K, Kohsaka S, Honda CN, Fairbanks CA, Taylor BK, Vulchanova L. Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling. Glia. PMID 28850719 DOI: 10.1002/Glia.23208 |
0.426 |
|
| 2017 |
Peterson C, Shah R, Kitto K, Goracke-Postle C, Fairbanks C, Wagner C, Wilcox G. (204) Inhibition of MOR-NMDAR interaction restores opioid efficacy and inhibits neuropathic pain The Journal of Pain. 18: S27. DOI: 10.1016/J.Jpain.2017.02.367 |
0.803 |
|
| 2017 |
Bruce D, Peterson C, Kitto K, Fairbanks C, Wilcox G. (199) Peripherally-restricted opioid combination therapy synergizes in multiple pain states The Journal of Pain. 18: S25-S26. DOI: 10.1016/J.Jpain.2017.02.106 |
0.623 |
|
| 2015 |
Chabot-Doré AJ, Millecamps M, Naso L, Devost D, Trieu P, Piltonen M, Diatchenko L, Fairbanks CA, Wilcox GL, Hébert TE, Stone LS. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors. Neuropharmacology. 99: 285-300. PMID 26254859 DOI: 10.1016/J.Neuropharm.2015.08.010 |
0.657 |
|
| 2015 |
Guedon JM, Wu S, Zheng X, Churchill CC, Glorioso JC, Liu CH, Liu S, Vulchanova L, Bekker A, Tao YX, Kinchington PR, Goins WF, Fairbanks CA, Hao S. Current gene therapy using viral vectors for chronic pain. Molecular Pain. 11: 27. PMID 25962909 DOI: 10.1186/S12990-015-0018-1 |
0.374 |
|
| 2015 |
Fairbanks CA, Goracke-Postle CJ. Neurobiological studies of chronic pain and analgesia: Rationale and refinements. European Journal of Pharmacology. 759: 169-81. PMID 25818751 DOI: 10.1016/J.Ejphar.2015.03.049 |
0.786 |
|
| 2015 |
Schuster DJ, Metcalf MD, Kitto KF, Messing RO, Fairbanks CA, Wilcox GL. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors. British Journal of Pharmacology. 172: 642-53. PMID 24827408 DOI: 10.1111/Bph.12774 |
0.763 |
|
| 2015 |
Chabot-Doré AJ, Millecamps M, Naso L, Devost D, Trieu P, Piltonen M, Diatchenko L, Fairbanks CA, Wilcox GL, Hébert TE, Stone LS. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors Neuropharmacology. 99: 285-300. DOI: 10.1016/j.neuropharm.2015.08.010 |
0.567 |
|
| 2014 |
Stone LS, German JP, Kitto KF, Fairbanks CA, Wilcox GL. Morphine and clonidine combination therapy improves therapeutic window in mice: synergy in antinociceptive but not in sedative or cardiovascular effects. Plos One. 9: e109903. PMID 25299457 DOI: 10.1371/Journal.Pone.0109903 |
0.656 |
|
| 2014 |
Wade CL, Fairbanks CA. The Self-administration of Analgesic Drugs in Experimentally Induced Chronic Pain. Current Topics in Behavioral Neurosciences. 20: 217-32. PMID 25205326 DOI: 10.1007/7854_2014_344 |
0.745 |
|
| 2014 |
Schuster DJ, Belur LR, Riedl MS, Schnell SA, Podetz-Pedersen KM, Kitto KF, McIvor RS, Vulchanova L, Fairbanks CA. Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5. Frontiers in Neuroanatomy. 8: 66. PMID 25147505 DOI: 10.3389/Fnana.2014.00066 |
0.598 |
|
| 2014 |
Schuster DJ, Dykstra JA, Riedl MS, Kitto KF, Belur LR, McIvor RS, Elde RP, Fairbanks CA, Vulchanova L. Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Frontiers in Neuroanatomy. 8: 42. PMID 24959122 DOI: 10.3389/Fnana.2014.00042 |
0.632 |
|
| 2014 |
Fairbanks CA, Peterson CD, Speltz RH, Riedl MS, Kitto KF, Dykstra JA, Braun PD, Sadahiro M, Salton SR, Vulchanova L. The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity. Pain. 155: 1229-37. PMID 24657450 DOI: 10.1016/J.Pain.2014.03.012 |
0.429 |
|
| 2014 |
Churchill C, Schuster D, Schnell S, Kitto K, Peterson C, Vulchanova L, Fairbanks C. (274) Differential gene transfer to the choroid plexus after intrathecal delivery or in vitro exposure to AAV5, AAV8, and AAV9 viral vectors The Journal of Pain. 15: S44. DOI: 10.1016/J.Jpain.2014.01.183 |
0.567 |
|
| 2014 |
Peterson C, Braun P, Schuster D, Schnell S, Kitto K, Churchill C, Wilcox G, Vulchanova L, Fairbanks C. (273) Expression of human arginine decarboxylase (hADC) in the spinal cord and dorsal root ganglia following intrathecal delivery of an AAV9-hADC vector reduces established chronic pain responses in rodents The Journal of Pain. 15: S44. DOI: 10.1016/J.Jpain.2014.01.182 |
0.766 |
|
| 2014 |
Fairbanks CA, Peterson CD. Biopharmaceutical considerations of opioid analgesics in models of self-administration: Review and summary Neurobiological Studies of Addiction in Chronic Pain States. 81-107. DOI: 10.1007/978-1-4939-1856-0_6 |
0.311 |
|
| 2014 |
Wade CL, Fairbanks CA. Opioid and non-opioid drug responding under states of chronic pain: A timeline spanning 1980 to present day Neurobiological Studies of Addiction in Chronic Pain States. 3-14. DOI: 10.1007/978-1-4939-1856-0_1 |
0.713 |
|
| 2013 |
Wade CL, Krumenacher P, Kitto KF, Peterson CD, Wilcox GL, Fairbanks CA. Effect of chronic pain on fentanyl self-administration in mice. Plos One. 8: e79239. PMID 24260176 DOI: 10.1371/Journal.Pone.0079239 |
0.784 |
|
| 2013 |
Schuster DJ, Kitto KF, Overland AC, Messing RO, Stone LS, Fairbanks CA, Wilcox GL. Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 13538-46. PMID 23946412 DOI: 10.1523/Jneurosci.4013-12.2013 |
0.816 |
|
| 2013 |
Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, et al. Agmatine: clinical applications after 100 years in translation. Drug Discovery Today. 18: 880-93. PMID 23769988 DOI: 10.1016/J.Drudis.2013.05.017 |
0.536 |
|
| 2013 |
Schuster DJ, Dykstra JA, Riedl MS, Kitto KF, Honda CN, McIvor RS, Fairbanks CA, Vulchanova L. Visualization of spinal afferent innervation in the mouse colon by AAV8-mediated GFP expression. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 25: e89-100. PMID 23252426 DOI: 10.1111/Nmo.12057 |
0.647 |
|
| 2012 |
Metcalf MD, Yekkirala AS, Powers MD, Kitto KF, Fairbanks CA, Wilcox GL, Portoghese PS. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors. Acs Chemical Neuroscience. 3: 505-9. PMID 22860219 DOI: 10.1021/Cn3000394 |
0.617 |
|
| 2012 |
Schuster D, Schnell S, Kitto K, Overland A, Stone L, Messing R, Fairbanks C, Wilcox G. Immunohistochemical evaluation of the localization of protein kinase C-epsilon in dorsal root ganglia and spinal cord. The Journal of Pain. 13: S42. DOI: 10.1016/J.Jpain.2012.01.179 |
0.787 |
|
| 2011 |
Winter TN, Elmquist WF, Fairbanks CA. OCT2 and MATE1 provide bidirectional agmatine transport. Molecular Pharmaceutics. 8: 133-42. PMID 21128598 DOI: 10.1021/Mp100180A |
0.752 |
|
| 2010 |
Vulchanova L, Schuster DJ, Belur LR, Riedl MS, Podetz-Pedersen KM, Kitto KF, Wilcox GL, McIvor RS, Fairbanks CA. Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Molecular Pain. 6: 31. PMID 20509925 DOI: 10.1186/1744-8069-6-31 |
0.737 |
|
| 2010 |
Pan G, Winter TN, Roberts JC, Fairbanks CA, Elmquist WF. Organic cation uptake is enhanced in bcrp1-transfected MDCKII cells. Molecular Pharmaceutics. 7: 138-45. PMID 19886673 DOI: 10.1021/Mp900177R |
0.749 |
|
| 2010 |
Overland AC, Kitto KF, Fairbanks CA, Stone LS, Wilcox GL. Specific involvement of PKC-ε in the synergistic interaction between agonists acting at alpha-2-adrenergic and delta-opioid receptors in spinal cord F1000research. 1. DOI: 10.7490/F1000Research.85.1 |
0.819 |
|
| 2010 |
Flores G, Kitto K, Wade C, Fairbanks C. Endogenous agmatine contributes to percutaneous electrical nerve stimulation evoked anti-allodynia The Journal of Pain. 11: S29. DOI: 10.1016/J.Jpain.2010.01.123 |
0.668 |
|
| 2010 |
Braun P, Riedl M, Kitto K, Fairbanks C, Vulchanova L. VGF-derived peptides function through p38 activation in spinal microglia The Journal of Pain. 11: S24. DOI: 10.1016/J.Jpain.2010.01.102 |
0.324 |
|
| 2009 |
Riedl MS, Braun PD, Kitto KF, Roiko SA, Anderson LB, Honda CN, Fairbanks CA, Vulchanova L. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13377-88. PMID 19846725 DOI: 10.1523/Jneurosci.1127-09.2009 |
0.359 |
|
| 2009 |
Overland AC, Kitto KF, Chabot-Doré AJ, Rothwell PE, Fairbanks CA, Stone LS, Wilcox GL. Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13264-73. PMID 19846714 DOI: 10.1523/Jneurosci.1907-09.2009 |
0.824 |
|
| 2009 |
Florio SK, Loh C, Huang SM, Iwamaye AE, Kitto KF, Fowler KW, Treiberg JA, Hayflick JS, Walker JM, Fairbanks CA, Lai Y. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. British Journal of Pharmacology. 158: 494-506. PMID 19732061 DOI: 10.1111/J.1476-5381.2009.00300.X |
0.39 |
|
| 2009 |
Wade CL, Eskridge LL, Nguyen HO, Kitto KF, Stone LS, Wilcox G, Fairbanks CA. Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance. The Journal of Pharmacology and Experimental Therapeutics. 331: 539-46. PMID 19684255 DOI: 10.1124/Jpet.109.155424 |
0.8 |
|
| 2009 |
Fairbanks CA, Stone LS, Wilcox GL. Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. Pharmacology & Therapeutics. 123: 224-38. PMID 19393691 DOI: 10.1016/J.Pharmthera.2009.04.001 |
0.655 |
|
| 2009 |
Fairbanks CA, Kitto KF, Nguyen HO, Stone LS, Wilcox GL. Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord. Anesthesiology. 110: 638-47. PMID 19212267 DOI: 10.1097/Aln.0B013E318195B51D |
0.643 |
|
| 2009 |
Wade C, Kitto K, Schuster D, Fairbanks C, Wilcox G. Chronic pain and opioid self-administration The Journal of Pain. 10: S23. DOI: 10.1016/J.Jpain.2009.01.098 |
0.801 |
|
| 2008 |
Wade CL, Schuster DJ, Domingo KM, Kitto KF, Fairbanks CA. Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration. European Journal of Pharmacology. 587: 135-40. PMID 18495108 DOI: 10.1016/J.Ejphar.2008.04.007 |
0.771 |
|
| 2008 |
Belur L, Fairbanks C, Vulchanova L, Podetz-Pedersen K, Low W, McIvor RS. 7. Gene delivery and biodistribution in the brain and spinal cord following intrathecal administration of adeno-associated virus serotype 5 vector Molecular Genetics and Metabolism. 93: 15-16. DOI: 10.1016/J.Ymgme.2007.10.019 |
0.382 |
|
| 2007 |
Stone LS, Kitto KF, Eisenach JC, Fairbanks CA, Wilcox GL. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 323: 899-906. PMID 17855473 DOI: 10.1124/Jpet.107.125526 |
0.599 |
|
| 2007 |
Goracke-Postle CJ, Overland AC, Riedl MS, Stone LS, Fairbanks CA. Potassium- and capsaicin-induced release of agmatine from spinal nerve terminals. Journal of Neurochemistry. 102: 1738-48. PMID 17539920 DOI: 10.1111/J.1471-4159.2007.04647.X |
0.8 |
|
| 2007 |
Goracke-Postle CJ, Overland AC, Stone LS, Fairbanks CA. Agmatine transport into spinal nerve terminals is modulated by polyamine analogs. Journal of Neurochemistry. 100: 132-41. PMID 17227436 DOI: 10.1111/J.1471-4159.2006.04193.X |
0.779 |
|
| 2007 |
Wade C, Roberts J, Kitto K, Fairbanks C. (661) The Journal of Pain. 8: S16. DOI: 10.1016/J.Jpain.2007.02.072 |
0.671 |
|
| 2007 |
Overland A, Goracke-Postle C, Stone L, Fairbanks C, Wilcox G. (605) The Journal of Pain. 8: S2. DOI: 10.1016/J.Jpain.2007.02.007 |
0.742 |
|
| 2006 |
Kitto KF, Fairbanks CA. Supraspinally administered agmatine prevents the development of supraspinal morphine analgesic tolerance. European Journal of Pharmacology. 536: 133-7. PMID 16546161 DOI: 10.1016/J.Ejphar.2006.01.053 |
0.395 |
|
| 2006 |
Goracke-Postle CJ, Nguyen HO, Stone LS, Fairbanks CA. Release of tritiated agmatine from spinal synaptosomes. Neuroreport. 17: 13-7. PMID 16361942 DOI: 10.1097/01.Wnr.0000192739.38653.Aa |
0.824 |
|
| 2005 |
Roberts JC, Grocholski BM, Kitto KF, Fairbanks CA. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 314: 1226-33. PMID 15933157 DOI: 10.1124/Jpet.105.086173 |
0.509 |
|
| 2005 |
King EW, Audette K, Athman GA, Nguyen HO, Sluka KA, Fairbanks CA. Transcutaneous electrical nerve stimulation activates peripherally located alpha-2A adrenergic receptors. Pain. 115: 364-73. PMID 15911163 DOI: 10.1016/J.Pain.2005.03.027 |
0.402 |
|
| 2004 |
Kaminski L, Grocholski B, Roberts J, Kitto K, Nguyen H, Goracke-Postle C, Morgan A, Fairbanks C. Endogenous pain modulation The Journal of Pain. 5: S1. DOI: 10.1016/J.Jpain.2004.02.541 |
0.785 |
|
| 2003 |
Stone LS, Fairbanks CA, Wilcox GL. Moxonidine, a mixed alpha(2)-adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia. Annals of the New York Academy of Sciences. 1009: 378-85. PMID 15028616 DOI: 10.1196/Annals.1304.051 |
0.622 |
|
| 2003 |
Nguyen HO, Goracke-Postle CJ, Kaminski LL, Overland AC, Morgan AD, Fairbanks CA. Neuropharmacokinetic and dynamic studies of agmatine (decarboxylated arginine). Annals of the New York Academy of Sciences. 1009: 82-105. PMID 15028573 DOI: 10.1196/Annals.1304.009 |
0.783 |
|
| 2003 |
Zwick M, Molliver DC, Lindsay J, Fairbanks CA, Sengoku T, Albers KM, Davis BM. Transgenic mice possessing increased numbers of nociceptors do not exhibit increased behavioral sensitivity in models of inflammatory and neuropathic pain. Pain. 106: 491-500. PMID 14659533 DOI: 10.1016/J.Pain.2003.09.016 |
0.411 |
|
| 2003 |
Yu CG, Fairbanks CA, Wilcox GL, Yezierski RP. Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats. The Journal of Pain : Official Journal of the American Pain Society. 4: 129-40. PMID 14622710 DOI: 10.1054/Jpai.2003.11 |
0.616 |
|
| 2003 |
Kehl LJ, Fairbanks CA. Experimental animal models of muscle pain and analgesia. Exercise and Sport Sciences Reviews. 31: 188-94. PMID 14571958 DOI: 10.1097/00003677-200310000-00006 |
0.329 |
|
| 2003 |
Fairbanks CA. Spinal delivery of analgesics in experimental models of pain and analgesia. Advanced Drug Delivery Reviews. 55: 1007-41. PMID 12935942 DOI: 10.1016/S0169-409X(03)00101-7 |
0.488 |
|
| 2003 |
Guo XH, Fairbanks CA, Stone LS, Loh HH. DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Pain. 104: 209-17. PMID 12855331 DOI: 10.1016/S0304-3959(03)00007-1 |
0.443 |
|
| 2002 |
Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. The Journal of Pharmacology and Experimental Therapeutics. 300: 282-90. PMID 11752127 DOI: 10.1124/Jpet.300.1.282 |
0.583 |
|
| 2001 |
Guo A, Simone DA, Stone LS, Fairbanks CA, Wang J, Elde R. Developmental shift of vanilloid receptor 1 (VR1) terminals into deeper regions of the superficial dorsal horn: correlation with a shift from TrkA to Ret expression by dorsal root ganglion neurons. The European Journal of Neuroscience. 14: 293-304. PMID 11553280 DOI: 10.1046/J.0953-816X.2001.01665.X |
0.375 |
|
| 2000 |
Yu CG, Marcillo AE, Fairbanks CA, Wilcox GL, Yezierski RP. Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport. 11: 3203-7. PMID 11043549 DOI: 10.1097/00001756-200009280-00031 |
0.59 |
|
| 2000 |
Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America. 97: 10584-9. PMID 10984543 DOI: 10.1073/Pnas.97.19.10584 |
0.769 |
|
| 2000 |
Fairbanks CA, Nguyen HO, Grocholski BM, Wilcox GL. Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology. 93: 765-73. PMID 10969310 DOI: 10.1097/00000542-200009000-00026 |
0.667 |
|
| 2000 |
Fairbanks CA, Wilcox GL. Spinal plasticity of acute opioid tolerance. Journal of Biomedical Science. 7: 200-12. PMID 10810238 DOI: 10.1007/Bf02255467 |
0.685 |
|
| 2000 |
Fairbanks CA, Posthumus IJ, Kitto KF, Stone LS, Wilcox GL. Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice. Pain. 84: 13-20. PMID 10601668 DOI: 10.1016/S0304-3959(99)00171-2 |
0.649 |
|
| 1999 |
Fairbanks CA, Wilcox GL. Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice Journal of Pharmacology and Experimental Therapeutics. 290: 403-412. PMID 10381806 |
0.528 |
|
| 1999 |
Fairbanks CA, Wilcox GL. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine Journal of Pharmacology and Experimental Therapeutics. 288: 1107-1116. PMID 10027848 |
0.596 |
|
| 1997 |
Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW, Wilcox GL. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport. 8: 3131-5. PMID 9331928 DOI: 10.1097/00001756-199709290-00025 |
0.679 |
|
| 1997 |
Fairbanks CA, Wilcox GL. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance Journal of Pharmacology and Experimental Therapeutics. 282: 1408-1417. PMID 9316854 |
0.604 |
|
| 1997 |
Kehl LJ, Fairbanks CA, Laughlin TM, Wilcox GL. Neurogenesis in postnatal rat spinal cord: A study in primary culture Science. 276: 586-589. PMID 9110976 DOI: 10.1126/Science.276.5312.586 |
0.619 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Ou XM, Udemgba C, Wang N, Dai X, Lomberk G, Seo S, Urrutia R, Wang J, Duncan J, Harris S, Fairbanks CA, Zhang X. Diabetes-causing gene, kruppel-like factor 11, modulates the antinociceptive response of chronic ethanol intake. Alcoholism, Clinical and Experimental Research. 38: 401-8. PMID 24428663 DOI: 10.1111/Acer.12258 |
0.3 |
|
| 2016 |
Laoharawee K, Podetz-Petersen KM, Kitto K, Vulchanova L, Fairbanks C, Kozarsky K, Low WC, McIvor RS. 86. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System to Prevent the Onset of Neurologic Deficits in a Murine Model of Mucopolysaccharidosis Type II Molecular Therapy. 24: S38. DOI: 10.1016/S1525-0016(16)32895-7 |
0.284 |
|
| 2019 |
Gore R, Riedl MS, Kitto KF, Fairbanks CA, Vulchanova L. AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection. Methods in Molecular Biology (Clifton, N.J.). 1950: 407-415. PMID 30783988 DOI: 10.1007/978-1-4939-9139-6_24 |
0.284 |
|
| 2023 |
Fairbanks CA, Peterson CD. The opioid receptor: emergence through millennia of pharmaceutical sciences. Frontiers in Pain Research (Lausanne, Switzerland). 4: 960389. PMID 38028425 DOI: 10.3389/fpain.2023.960389 |
0.272 |
|
| 2016 |
Laoharawee K, Podetz-Petersen KM, Kitto KF, Vulchanova L, Fairbanks CA, Kozarsky K, Low WC, Scott McIvor R. AAV9 mediated correction of iduronate-2-sulfatase deficiency in the central nervous system of mucopolysaccharidosis type II mice Molecular Genetics and Metabolism. 117: S70. DOI: 10.1016/J.Ymgme.2015.12.329 |
0.269 |
|
| 2017 |
Laoharawee K, Podetz-Pedersen KM, Nguyen TT, Evenstar LB, Kitto KF, Nan Z, Fairbanks CA, Low WC, Kozarsky KF, McIvor RS. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice By CNS-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer. Human Gene Therapy. PMID 28478695 DOI: 10.1089/Hum.2016.184 |
0.266 |
|
| 2016 |
Belur L, Buckvold M, Podetz-Pedersen KM, Riedl M, Vulchanova L, Hanson L, Fairbanks C, Kozarsky K, Frey WH, Low WC, Mclvor RS. 25. Intranasal Gene Delivery of AAV Iduronidase: An Effective and Non-Invasive Approach for Treatmentof CNS Disease in a Murine Model of MPS Type I Molecular Therapy. 24: S12. DOI: 10.1016/S1525-0016(16)32834-9 |
0.265 |
|
| 2015 |
Belur L, Buckvold M, Podetz-Pedersen K, Riedl M, Vulchanova L, Hanson LR, Kozarsky K, Frey WH, Low WC, Fairbanks C, Scott McIvor R. 706. Non-Invasive Intranasal Administration of AAV9-Iduronidase Prevents Emergence of Neurologic Disease and Neurocognitive Dysfunction in a Murine Model of Mucopolysaccharidosis Type I Molecular Therapy. 23: S281. DOI: 10.1016/S1525-0016(16)34315-5 |
0.257 |
|
| 2014 |
Fairbanks CA, Martin TJ. Neurobiological studies of addiction in chronic pain states Neurobiological Studies of Addiction in Chronic Pain States. 1-132. DOI: 10.1007/978-1-4939-1856-0 |
0.252 |
|
| 2017 |
Scott McIvor R, Kozarsky K, Laoharawee K, Podetz-Pedersen KM, Kitto K, Riedl M, Whitley CB, Vulchanova L, Fairbanks CA, Frey WH, Low WC, Belur LR. Relative effectiveness of different routes of AAV administration for gene therapy of mucopolysaccharidosis Molecular Genetics and Metabolism. 120: S93. DOI: 10.1016/J.Ymgme.2016.11.230 |
0.25 |
|
| 2014 |
McIvor RS, Nan Z, Podetz-Pedersen KM, Kitto K, Hanson LR, Wolf DA, Kozarsky K, Fairbanks CA, Frey WH, Low WC, Belur LR. Intrathecal and intranasal infusion of adeno-associated virus vector: non-invasive routes of administration achieving corrective levels of iduronidase expression throughout the brain for gene therapy of mucopolysaccharidosis type I Molecular Genetics and Metabolism. 111: S75-S76. DOI: 10.1016/J.Ymgme.2013.12.174 |
0.241 |
|
| 2016 |
Belur L, Buckvold M, Podetz-Pedersen KM, Riedl M, Vulchanova L, Hanson LR, Fairbanks C, Kozarsky K, Frey WH, Low WC, Scott McIvor R. Intranasal gene delivery of AAV9 iduronidase: A non-invasive and effective gene therapy approach for prevention of neurologic disease in a murine model of mucopolysaccharidosis type I Molecular Genetics and Metabolism. 117: S26. DOI: 10.1016/J.Ymgme.2015.12.195 |
0.233 |
|
| 2016 |
Cook J, Kitto K, Riedl M, Fairbanks C, Vulchanova L. (291) Complement-mediated effects of the VGF peptide TLQP-21. The Journal of Pain : Official Journal of the American Pain Society. 17: S48-S49. PMID 28162522 DOI: 10.1016/J.Jpain.2016.01.197 |
0.219 |
|
| 2022 |
Skorput AGJ, Gore R, Schorn R, Riedl MS, Marron Fernandez de Velasco E, Hadlich B, Kitto KF, Fairbanks CA, Vulchanova L. Targeting the somatosensory system with AAV9 and AAV2retro viral vectors. Plos One. 17: e0264938. PMID 35271639 DOI: 10.1371/journal.pone.0264938 |
0.217 |
|
| 2023 |
Gore R, Esmail T, Pflepsen K, Marron Fernandez de Velasco E, Kitto KF, Riedl MS, Karlen A, McIvor RS, Honda CN, Fairbanks CA, Vulchanova L. AAV-mediated gene transfer to colon-innervating primary afferent neurons. Frontiers in Pain Research (Lausanne, Switzerland). 4: 1225246. PMID 37599864 DOI: 10.3389/fpain.2023.1225246 |
0.194 |
|
| 2021 |
Belur LR, Romero M, Lee J, Podetz-Pedersen KM, Nan Z, Riedl MS, Vulchanova L, Kitto KF, Fairbanks CA, Kozarsky KF, Orchard PJ, Frey WH, Low WC, McIvor RS. Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I. Frontiers in Molecular Neuroscience. 14: 618360. PMID 34040503 DOI: 10.3389/fnmol.2021.618360 |
0.126 |
|
| 2015 |
Laoharawee K, Podetz-Pedersen KM, Kitto K, Vulchanova L, Fairbanks C, Kozarsky K, Low WC, Scott McIvor R. 369. AAV9 Mediated Correction of Iduronate-2-Sulfatase Deficiency in the Central Nervous System of Mucopolysaccharidosis Type II Mice Molecular Therapy. 23: S146. DOI: 10.1016/S1525-0016(16)33978-8 |
0.125 |
|
| 2024 |
Smith MC, Belur LR, Karlen AD, Erlanson O, Furcich J, Lund TC, Seelig D, Kitto KF, Fairbanks CA, Kim KH, Buss N, McIvor RS. Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice. Molecular Therapy. Methods & Clinical Development. 32: 101201. PMID 38374962 DOI: 10.1016/j.omtm.2024.101201 |
0.12 |
|
| Hide low-probability matches. |